Chicago、ILにおける統合失調症の臨床試験
Chicagoとその周辺地域（約30マイル以内）の拠点で、統合失調症に関する21件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
被験者募集中健康なボランティア歓迎
- The University of Chicago, Chicago
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
被験者募集中第1相
- Uptown Research Institute, Chicago
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
被験者募集中第3相
- Local Institution - 0067, Chicago
- Pillar Clinical Research -Chicago, Chicago
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
被験者募集中第3相
- Neurocrine Clinical Site, Chicago
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
被験者募集中第3相
- Local Institution - 0175, Chicago
- EmVenio Research Center - Prime Healthcare, Chicago
A Study of Brenipatide in Adult Participants With Schizophrenia
被験者募集中第2相
- Re:Cognition Health - Chicago, Chicago
52-week Open Label Safety-Tolerability Study
被験者募集中第3相
- Pillar Clinical Research, Chicago
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
被験者募集中第3相
- Local Institution - 0122, Chicago
- EmVenio Research Center - Prime Healthcare, Chicago
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
被験者募集中第1相
- Uptown Research Institute, Chicago
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
被験者募集中第2相
- Clinical Site, Chicago
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
被験者募集中第3相
- Alkermes Investigator Site, Chicago
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
被験者募集中第2相
- Uptown Research Institute LLC, Chicago
- Pillar Clinical Research LLC, Chicago
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
被験者募集中第3相
- Pillar Clinical Research, Chicago
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
被験者募集中第2相
- Uptown Research Institute, Chicago
A Study to Evaluate the Effect of KarXT on Urological Safety
被験者募集中第4相
- Uptown Research Institute, Chicago
- Pillar Clinical Research -Chicago, Chicago
CLOZAPINE Response in Biotype-1
被験者募集中第4相
- University of Chicago, Chicago
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
被験者募集中観察研究
- University of Chicago Medical Center, Chicago
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
被験者募集中第3相
- Neurocrine Clinical Site, Chicago
Randomized Withdrawal Study in Patients With Schizophrenia
被験者募集中第3相
- Vanda Investigational Site, Chicago
Study of ALTO-101 in Patients With Schizophrenia
被験者募集中第2相
- Site 5056, Chicago
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
被験者募集中第3相健康なボランティア歓迎
- Reviva site, Chicago
他の都市における統合失調症の試験
- Atlanta, GA22件の研究
- Little Rock, AR19件の研究
- Hollywood, FL15件の研究
- Boston, MA14件の研究
- Houston, TX13件の研究
- San Diego, CA13件の研究
- Hialeah, FL13件の研究
- New York City, NY13件の研究
- Austin, TX13件の研究
- Garden Grove, CA12件の研究
- Germantown, MD11件の研究
- Miami, FL10件の研究
Chicagoにおける他の研究
- 非小細胞肺癌61件の研究
- 乳がん58件の研究
- がん（全種類）51件の研究
- 転移性癌45件の研究
- 前立腺がん45件の研究
- 肥満症41件の研究
- 肺がん41件の研究
- 卵巣がん36件の研究
- 脳卒中34件の研究
- 大腸癌33件の研究
- 心不全31件の研究
- 過体重28件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。